<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Bipolar_Disorder.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:22 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1167002">
<meta name="Category" content="Concern">
<meta name="Article" content="Bipolar_Disorder">
<title>Enfermedad Bipolar-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Enfermedad Bipolar</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Bipolar_Disorder.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Ransford CP. A role for amines in the antidepressant effect of exercise: a
review. <em>Med Sci Sports Exerc</em> 1982;14:1&#8211;10 [review].</li>

<li class="Ref">Lykouras E, Garelis E, Varsou E, Stefanis CN. Physical activity and plasma
cyclic adenosine monophosphate levels in manic-depressive patients and healthy adults. <em>Am
J Psychiatry</em> 1979;136:540&#8211;2.</li>

<li class="Ref">Norman TC, Mathews W, Yohe CD. A case study on the effects of strenuous
exercise on serum lithium levels. <em>Nebr Med J</em> 1987;72:224&#8211;5.</li>

<li class="Ref">Adams PB, Lawson S, Sanigorski A, Sinclair AJ. Arachidonic acid to
eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of
depression. <em>Lipids</em> 1996;31 Suppl:S157&#8211;61.</li>

<li class="Ref">Maes M, Christophe A, Delanghe J, et al. Lowered omega 3 polyunsaturated fatty
acids in serum phospholipids and cholesterol esters of depressed patients. <em>Psychiatry
Res</em> 1999;85:275&#8211;91.</li>

<li class="Ref">Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar
disorder. A preliminary double-blind, placebo-controlled trial. <em>Arch Gen Psychiatr</em>
1999;56:407&#8211;12.</li>

<li class="Ref">Young SN. Behavioral effects of dietary neurotransmitter precursors: basic and
clinical aspects. <em>Neurosci Biobehav Rev</em> 1996;20:313&#8211;23 [review].</li>

<li class="Ref">Riemann D, Vorderholzer U. Treatment of depression and sleep disorders.
Significance of serotonin and L-tryptophan in pathophysiology and therapy. <em>Fortschr
Med</em> 1998;116:40&#8211;2 [review].</li>

<li class="Ref">Chouinard G, Jones BD, Young SN, Annable L. Potentiation of lithium by
tryptophan in a patient with bipolar illness. <em>Am J Psychiatry</em>
1979;136:719&#8211;20.</li>

<li class="Ref">Hedaya RJ. Pharmacokinetic factors in the clinical use of tryptophan. <em>J
Clin Psychopharmacol</em> 1984;4:347&#8211;8.</li>

<li class="Ref">Prange AJ, Wilson IC, Lynn CW, et al. L-tryptophan in mania: contribution to a
permissive hypothesis of affective disorders. <em>Arch Gen Psychiatry</em>
1974;30:56&#8211;62.</li>

<li class="Ref">Chambers CA, Naylor GJ. A controlled trial of L-tryptophan in mania. <em>Br J
Psychiatry</em> 1978;132:555&#8211;9.</li>

<li class="Ref">Murphy DL, Maker M, Goodwin FK, et al. L-tryptophan in affective disorders:
indoleamine changes and differential clinical effects. <em>Psychopharmacologia</em>
1974;34:11&#8211;20.</li>

<li class="Ref">van Praag HM, de Haan S. Chemoprophylaxis of depressions. An attempt to
compare lithium with 5-hydroxytryptophan. <em>Acta Psychiatr Scand Suppl</em>
1981;290:191&#8211;201.</li>

<li class="Ref">Mendlewicz J, Youdim MB. Antidepressant potentiation of 5-hydroxytryptophan by
L-deprenil in affective illness. <em>J Affect Disord</em> 1980;2:137&#8211;46.</li>

<li class="Ref">Rosenbaum JF, Fava M, Faulk WE, et al. The antidepressant potential of oral
S-adenosyl-l-methionine. <em>Acta Psychiatr Scand</em> 1990;81:432&#8211;6.</li>

<li class="Ref">Friedel HA, Goa KL, Benfield P. S-Adenosyl-l-methionine: A review of its
pharmacological properties and therapeutic potential in liver dysfunction and affective
disorders in relation to its physiological role in cell metabolism. <em>Drugs</em>
1989;38:389&#8211;417 [review].</li>

<li class="Ref">Carney MWP, Chary TKN, Bottiglieri T. The switch mechanism in affective
illness and oral S-adenosylmethionine (SAM). <em>Br J Psychiatry</em>
1987;150:724&#8211;5.</li>

<li class="Ref">Carney MWP, Chary TKN, Bottiglieri T. The switch mechanism in affective
illness and oral S-adenosylmethionine (SAM). <em>Br J Psychiatry</em>
1987;150:724&#8211;5.</li>

<li class="Ref">Carney MWP, Chary TKN, Bottiglieri T, Reynolds EH. The switch mechanism and
bipolar/unipolar dichotomy. <em>Br J Psychiatry</em> 1989;154:48&#8211;51.</li>

<li class="Ref">Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of
affective illness? <em>Am J Psychiatry</em> 1987;144:1403&#8211;11.</li>

<li class="Ref">Rosenbaum JF, Fava M, Faulk WE, et al. The antidepressant potential of oral
S-adenosyl-l-methionine. <em>Acta Psychiatr Scand</em> 1990;81:432&#8211;6.</li>

<li class="Ref">Botiglieri T. Folate, vitamin B12, and neuropsychiatric disorders. <em>Nutr
Rev</em> 1996;54:382&#8211;90 [review].</li>

<li class="Ref">Fine EJ, Soria ED. Myths about vitamin B12 deficiency. <em>Southern Med J</em>
1991;84:1475&#8211;81.</li>

<li class="Ref">Hasanah CI, Khan UA, Musalmah M, Razali SM. Reduced red-cell folate in mania.
<em>J Affect Disord</em> 1997;46:95&#8211;9.</li>

<li class="Ref">McKeon P, Shelley R, O&#8217;Regan S, O&#8217;Broin J. Serum and red cell
folate and affective morbidity in lithium prophylaxis. <em>Acta Psychiatr Scand</em>
1991;83:199&#8211;201.</li>

<li class="Ref">Lee S, Chow CC, Shek CC, et al. Folate concentration in Chinese psychiatric
outpatients on long-term lithium treatment. <em>J Affect Disord</em>
1992;24:265&#8211;70.</li>

<li class="Ref">Stern SL, Brandt JT, Hurley RS, et al. Serum and red cell folate
concentrations in outpatients receiving lithium carbonate. <em>Int Clin Psychopharmacol</em>
1988;3:49&#8211;52.</li>

<li class="Ref">Coppen A, Abou-Saleh MT. Plasma folate and affective morbidity during
long-term lithium therapy. <em>Br J Psychiatry</em> 1982;141:87&#8211;9.</li>

<li class="Ref">Lee S, Chow CC, Shek CC, et al. Folate concentration in Chinese psychiatric
outpatients on long-term lithium treatment. <em>J Affect Disord</em>
1992;24:265&#8211;70.</li>

<li class="Ref">Stern SL, Brandt JT, Hurley RS, et al. Serum and red cell folate
concentrations in outpatients receiving lithium carbonate. <em>Int Clin Psychopharmacol</em>
1988;3:49&#8211;52.</li>

<li class="Ref">Coppen A, Chaudhry S, Swade C. Folic acid enhances lithium prophylaxis. <em>J
Affect Disord</em> 1986;10:9&#8211;13.</li>

<li class="Ref">Goggans FC. A case of mania secondary to vitamin B12 deficiency. <em>Am J
Psychiatry</em> 1984;141:300&#8211;1.</li>

<li class="Ref">Verbanck PM, LeBon O. Changing psychiatric symptoms in a patient with vitamin
B12 deficiency. <em>J Clin Psychiatry</em> 1991;52:182&#8211;3 [letter].</li>

<li class="Ref">Naylor GJ. Vanadium and manic depressive psychosis. <em>Nutr Health</em>
1984;3:79&#8211;85 [review].</li>

<li class="Ref">Naylor GJ, Smith AH. Vanadium: a possible aetiological factor in manic
depressive illness. <em>Psychol Med</em> 1981;11:249&#8211;56.</li>

<li class="Ref">Kay DS, Naylor GJ, Smith AH, Greenwood C. The therapeutic effect of ascorbic
acid and EDTA in manic-depressive psychosis: double-blind comparisons with standard
treatments<em>. Psychol Med</em> 1984;14:533&#8211;9.</li>

<li class="Ref">Shimon H, Agam G, Belmaker RH, et al. Reduced frontal cortex inositol levels
in postmortem brain of suicide victims and patients with bipolar disorder. <em>Am J
Psychiatry</em> 1997;154:1148&#8211;50.</li>

<li class="Ref">Fauroux CM, Freeman S. Inhibitors of inositol monophosphatase. <em>J Enzyme
Inhib</em> 1999;14:97&#8211;108 [review].</li>

<li class="Ref">Belmaker RH, Agam G, van Calker D, et al. Behavioral reversal of lithium
effects by four inositol isomers correlates perfectly with biochemical effects on the PI
cycle: depletion by chronic lithium of brain inositol is specific to hypothalamus, and
inositol levels may be abnormal in postmortem brain from bipolar patients. <em>
Neuropsychopharmacology</em> 1998;19:220&#8211;32 [review].</li>

<li class="Ref">Belmaker RH, Bersudsky Y, Agam G, et al. How does lithium work on manic
depression? Clinical and psychological correlates of the inositol theory. <em>Annu Rev
Med</em> 1996;47:47&#8211;56 [review].</li>

<li class="Ref">Levine J, Barak Y, Gonzalves M, et al. Double-blind, controlled trial of
inositol treatment of depression. <em>Am J Psychiatry</em> 1995;152:792&#8211;4.</li>

<li class="Ref">Levine J, Barak Y, Kofman O, Belmaker RH. Follow-up and relapse analysis of an
inositol study of depression. <em>Isr J Psychiatry Relat Sci</em> 1995;32:14&#8211;21.</li>

<li class="Ref">Souza FG, Mander AJ, Foggo M, et al. The effects of lithium discontinuation
and the non-effect of oral inositol upon thyroid hormones and cortisol in patients with
bipolar affective disorder. <em>J Affect Disord</em> 1991;22:165&#8211;70.</li>

<li class="Ref">Grisaru N, Belmaker RH. Lithium dosage and inositol levels. <em>Br J
Psychiatry</em> 1994;164:133&#8211;4 [letter].</li>

<li class="Ref">Levine J, Witztum E, Greenberg BD, Barak Y. Inositol-induced mania? <em>Am J
Psychiatry</em> 1996;153:839 [letter].</li>

<li class="Ref">Stoll AL, Sachs GS, Cohen MB, et al. Choline in the treatment of rapid-cycling
bipolar disorder: clinical and neurochemical findings in lithium-treated patients. <em>Biol
Psychiatry</em> 1996;40:382&#8211;8.</li>

<li class="Ref">Carman JS, Wyatt RJ. Calcium: bivalent cation in the bivalent psychoses. <em>
Biol Psychiatry</em> 1979;14:295&#8211;336 [review].</li>

<li class="Ref">Naylor GJ. Vanadium and manic depressive psychosis. <em>Nutr Health</em>
1984;3:79&#8211;85 [review].</li>

<li class="Ref">BJ, Simpson JSA, Ferre RC, et al. Effective mood stabilization with a chelated
mineral supplement: an open-label trial in bipolar disorder. <em>J Clin Psychiatry</em>
2001;62:936&#8211;44.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Bipolar_Disorder.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:22 GMT -->
</html>

